1. Home
  2. RRC vs MDGL Comparison

RRC vs MDGL Comparison

Compare RRC & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Range Resources Corporation

RRC

Range Resources Corporation

HOLD

Current Price

$41.17

Market Cap

10.1B

Sector

Energy

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$518.07

Market Cap

11.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RRC
MDGL
Founded
1976
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
11.5B
IPO Year
1996
2005

Fundamental Metrics

Financial Performance
Metric
RRC
MDGL
Price
$41.17
$518.07
Analyst Decision
Hold
Strong Buy
Analyst Count
18
12
Target Price
$43.67
$674.45
AVG Volume (30 Days)
2.3M
264.2K
Earning Date
04-21-2026
05-06-2026
Dividend Yield
0.92%
N/A
EPS Growth
151.38
41.32
EPS
1.44
N/A
Revenue
$3,115,515,000.00
$180,133,000.00
Revenue This Year
$15.60
$58.39
Revenue Next Year
$9.73
$48.55
P/E Ratio
$28.50
N/A
Revenue Growth
28.90
N/A
52 Week Low
$32.60
$265.00
52 Week High
$48.31
$615.00

Technical Indicators

Market Signals
Indicator
RRC
MDGL
Relative Strength Index (RSI) 44.18 51.29
Support Level $40.16 $498.34
Resistance Level $44.24 $554.40
Average True Range (ATR) 1.02 23.54
MACD -0.00 -1.47
Stochastic Oscillator 36.68 41.89

Price Performance

Historical Comparison
RRC
MDGL

About RRC Range Resources Corporation

Range Resources is an exploration and production firm whose operations represent a pure play in the Marcellus shale, located in the Appalachian region of Southwest Pennsylvania. The company went public as Lomak Petroleum in 1980 and later reorganized as Range Resources in 1998. After an expensive 10-year venture with a multi-basin strategy, Range Resources found its identity as an Appalachian natural gas producer, offloading its Permian assets in 2013. Range quickly became a leading US gas producer after its merger with Memorial Resource Development in 2016. Following the merger, Range saw its operational unit costs rise to an uncompetitive level and subsequently sold the assets in 2020 to return to its roots as an Appalachian producer.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: